Having completed his PhD in Microbiology at the University of Queensland in 2022, James has since been working to develop innovative high-throughput methods for culturing novel bacterial and archaea from human and other animal microbiomes.
James plays a leading role in AHMB’s scientific direction, overseeing research and development initiatives that advance our understanding of the human microbiome and its role in health and disease. He also provides expert input into the validation of biobanking processes to support AHMB’s compliance with national and international standards, including the ongoing accreditation process with the National Association of Testing Authorities (NATA).